This article is more than 5 years old. Information may no longer be current.

VIDEO: MedImmune collaborations produce three discoveries in COPD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

PHILADELPHIA — Roland Kolbeck, vice president of research and development for Respiratory, Inflammation & Autoimmunity at MedImmune, spoke with Healio Rheumatology about the company’s collaborations with academic institutions.

Kolbeck mentioned how MedImmune’s partnerships with academic institutions led to the discoveries that the interleukin-33 cytokine is expressed in the lungs of patients with chronic obstructive pulmonary disease (COPD), that immunoglobulin E binds to immune complexes in patients with lupus and that the innate lymphoid cell produces different types of cytokines from other cells in patients with COPD.